Patent · US Active

N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors

US7781481B2 · kind B2 · utility

1Cited by

4References

7Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Jose M. Carballido Herrera · Allschwil, CH
Herbert Jaksche · Wien, AT
Philipp Lehr · Spittal an der Drau, AT
Gudrun Werner · Wien, AT
Anthony Winiski · Wien, AT

Key dates

Filing date	Dec 22, 2006
Grant date	Aug 24, 2010
Priority date	—
Expiry date	Jan 6, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.